−0.3242USD
−81.351MUSD
250.567M
About Ocugen, Inc.
Sector
CEO
Shankar Musunuri
Headquarters
Malvern
Website
Employees (FY)
84
Founded
2013
ISIN
US67577C1053
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
OCUGENHUGE INVESTORS.
A fully integrated, patient-centric biotech company focused on vaccines in support of public health and gene and cell therapies
HUGE FUTURE POTENTIAL
OCUGENThe wyckoff method is a very accurate method, There are many variations and purposes--soley to liquidate others or take shares from retail or weak hands, To sell of shares to FOMO traders or breakout traders. Liquidating Other institutions or create misleading Bullish signals and prices to entice in
OCUGEN...parallel channel pattern daily vs hourlyGreen is a parallel channel pattern @ daily time frame
BLue is a parallel channel pattern @ hourly time frame
Depending on your trading strategy/Time frame....it still follows the trend.
When we gonna break the 2.90 Resistance??
OCGNOCGN is changing his structure to upside, all levels mentioned on charts for up side, accamulate it in range for mentioned tps .
OCGN Earnings Tomorrow! $15 Strike Price calls! WOWOcugen is a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and vaccines.
They announced yesterday that it will host a conference call to provide a business update and discuss its first quarter 2022 financial results tomorrow, May 6, bef
Ocugen: still alive or dead forever?Ocugen is still week but it shows small signs of reversal.
It can bounce from 2.20 to 2.40 in the coming week for a 10% gain.
1st target 2.40
2nd target 2.60
This is not an investment advice.
OCGN run upLooking for a pullback on Monday then a run up to the fib levels. Will it get a squeeze? Let's see. Closed over the 8 EMA and hoping for it to stay above it.
Ocugen IncASDAQ:OCGN) is a clinical-stage biopharmaceutical company .
link to VCHART indicator will be published in 12 days due to tradingview restrictions
Ocugen ocgn Strong candles Big target 10.28hi all bro... OCUGEN
firts target. 5.05 second 5.87 . and 6.10 big target:10.28
*****important- *****
thin line above price is the first target. thin line below price is support.. stop point. Fibonacci correction between the highest price and lowest fiat in the chart area are thick lines.. t
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
